Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
OBJECTIVE: To analyze damage occurring in patients with Wegener's granulomatosis (WG) enrolled in the WG Etanercept Trial (WGET) and to correlate that damage with disease activity, adverse events, and quality of life. METHODS: The Vasculitis Damage Index (VDI) was applied to all 180 patients a...
Κύριοι συγγραφείς: | Seo, P, Min, Y, Holbrook, J, Hoffman, G, Merkel, P, Spiera, R, Davis, J, Ytterberg, SR, St Clair, E, McCune, W, Specks, U, Allen, N, Luqmani, R, Stone, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2005
|
Παρόμοια τεκμήρια
-
Damage from Wegener's granulomatosis and its treatment: Prospective data from the Wegener's granulomatosis Etanercept Trial (WGET).
ανά: Seo, P, κ.ά.
Έκδοση: (2004) -
Design of the Wegener's Granulomatosis Etanercept Trial (WGET)
ανά: Stone, J, κ.ά.
Έκδοση: (2002) -
Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis
ανά: Falk, R, κ.ά.
Έκδοση: (2011) -
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
ανά: Falk, R, κ.ά.
Έκδοση: (2011) -
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.
ανά: Falk, R, κ.ά.
Έκδοση: (2011)